key: cord-0804816-euecm9n4
authors: Hussain, Azhar; Roberts, Neil; Oo, Aung
title: Prosthetic aortic valve endocarditis complicated by COVID‐19 and hemorrhage
date: 2020-05-22
journal: J Card Surg
DOI: 10.1111/jocs.14643
sha: 97c040c5f47fa3912908a2899e21214fa37e6ad9
doc_id: 804816
cord_uid: euecm9n4

The novel coronavirus, now termed SARS‐CoV‐2, has caused a significant global impact in the space of 4 months. Almost all elective cardiac surgical operations have been postponed with only urgent and emergency operations being considered in order to maximise resource utilisation. We present a case of a 69‐year old lady with an infected prosthetic aortic valve for consideration of urgent inpatient surgery. Despite being asymptomatic and testing negative initially for COVID‐19 RT‐PCR swab, further investigations with CT revealed suspicious findings. She subsequently tested positive on a repeat swab and unfortunately deteriorated rapidly with complications including gastro‐intestinal and intracerebral haemorrhage.

with a heart rate of 84. She was saturating at 96%, a respiratory rate of 18, with no supplemental oxygen and clinically very stable from a respiratory point of view. Physical examination was unremarkable except for an ejection systolic murmur. There was no clinical evidence of heart failure. She was transferred to our institution for surgical management a week later.

Her past medical history is significant for a tissue aortic 

The novel coronavirus, now termed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a significant global impact on the economy, politics, and health in the space of 4 months. COVID-19 (the clinical syndrome from the virus) has been declared a pandemic by the World Health Organization. In most cases, fever is the most common presenting symptom followed by cough. 2 The natural disease process can be complicated by acute respiratory distress syndrome, multiorgan failure, and ultimately death. The prevalence of COVID-19 in patients with underlying cardiovascular disease is under-reported with evidence that pre-existing cardiac disease can render patients more vulnerable to the disease process. 3 We report the first case of active prosthetic valve endocarditis complicated by COVID-19.

Establishing a diagnosis of COVID-19 using RT-PCR is not without its limitations. The availability of testing, clinical suspicion complicated by active endocarditis and a high false-negative rate with the current test have made it difficult to diagnose in a timely F I G U R E 1 A, CT chest showing early signs supportive of COVID-19 pneumonia when the patient was COVID-19 swab negative and clinically stable. B, Transthoracic echocardiogram on day 7 after admission to our institution. C, CXR showing widespread infiltrative changes on day 10, intubated and ventilated. D, CT head on day 18 of admission before death. COVID-19, coronavirus disease 2019; CT, computed tomography; CXR, chest X-ray fashion. 4 Initial swab test was negative at the referring institution, which raises concerns that this may have been a false negative result.

However, contact with multiple health workers and the inter-hospital transfer itself may have inadvertently exposed her to iatrogenic COVID-19 contraction. Given the patient's clinical history and presentation, it is likely that the endocarditis almost certainly preceded COVID-19, rather than COVID-19 complicated by endocarditis.

CT thorax changes may even precede RT-PCR findings and clinical signs of COVID-19 as alluded to in a recent study; the inclusion of CT thorax has now become part of routine preoperative cardiac surgical workup in our institution during this pandemic. 5 The standard of treatment in active prosthetic valve endocarditis with suspicion of a developing aortic root abscess almost always necessitates surgical replacement. The CT findings, however, played an instrumental role in the heart team's decision to continue medical therapy initially, as the effects of COVID-19 pneumonia on bypass followed by mechanical ventilation during recovery are unknown. In hindsight, this was most likely the correct decision given that the patient deteriorated ultimately from respiratory COVID-19 complications rather than a cardiac complication.

Recent studies from Wuhan, China, have suggested that COVID-19 could also manifest in significant abnormal coagulation parameters, particularly longer prothrombin (PT) and activated partial thromboplastin (APTT) times. 6 In contrast, during the SARS-CoV-1 epidemic of 2014, a higher risk of vessel thrombosis predisposed to a worse prognosis, and patients were routinely anticoagulated, a theme which is continuing in current patients with COVID-19. Our patient had mildly elevated APTT (35 seconds) with normal PT values throughout and it is unlikely that these would have caused her sudden GI bleed. More likely, it was a stress injury that precipitated an acute rupture from an existing Dieulafoy's lesion, a well-documented phenomenon in patients with acute hospitalization. 7 She was started on IV heparin post endoscopy for atrial fibrillation and subsequent requirement for renal replacement therapy. It is postulated that her acute intracerebral bleed is likely secondary to heparin therapy (based on the CT report) and possibly an as yet unknown clinical disease manifestation of COVID-19.

Our case highlights important facets of managing complex cardiac surgical patients during this pandemic. First, patients who fall into the high-risk surgical category should be discussed at an extended heart team meeting particularly during this crisis. We involved radiologists in these discussions due to the addition of routine CT to help clarify image interpretation, which was done remotely via video conferencing of all specialists. This proved invaluable in our case where the patient initially tested negative for COVID-19. Second, it is important to be vigilant about the extracardiac clinical manifestations of COVID-19, whether specific or nonspecific to the COVID-19 disease process. The role of cardiac surgery and bypass in active COVID-19 infection is still yet to be determined and further studies are clearly needed to determine the right approach.

SCTS cardiothoracic practice during Covid-19 outbreak

Clinical characteristics of coronavirus disease 2019 in China

At the heart of COVID-19

Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19

Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Dieulafoy's lesion: current trends in diagnosis and management

The authors declare that there are no conflict of interests.

Individual consent was obtained from each patient. Local institutional ethical processes were followed.

http://orcid.org/0000-0003-3941-4553